Market Cap 1.60B
Revenue (ttm) 1.18B
Net Income (ttm) -730.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 9.09
Profit Margin -62.03%
Debt to Equity Ratio 2.16
Volume 39,200
Avg Vol 188,328
Day's Range N/A - N/A
Shares Out 76.31M
Stochastic %K 38%
Beta N/A
Analysts Sell
Price Target $40.00

Company Profile

Endo, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally. The company offers products for the treatment of conditions in urology, orthopedics, and endocrinology. It is involved in the developing additional indications for XIAFLEX in clinical development, including plantar fibromatosis and plantar fasciitis, as well as others are in pre-clinical development, including arthrofibrosis of the k...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 484-216-0000
Address:
9 Great Valley Parkway, Malvern, United States
Latest News on NDOI
No data available.